Current studies conducted in human and animal models for obesity, diabetes, and atherosclerosis have reported on the potential role of adiponectin and adiponectin receptors for these metabolic diseases. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.